Diacylglycerol kinase a (DGKa), by phosphorylating diacylglycerol into phosphatidic acid, provides a key signal driving cell migration and matrix invasion. We previously demonstrated that in epithelial cells activation of DGKa activity promotes cytoskeletal remodeling and matrix invasion by recruiting atypical PKC at ruffling sites and by promoting RCP-mediated recycling of a5b1 integrin to the tip of pseudopods. In here we investigate the signaling pathway by which DGKa mediates SDF-1a-induced matrix invasion of MDA-MB-231 invasive breast carcinoma cells. Indeed we showed that, following SDF-1a stimulation, DGKa is activated and localized at cell protrusion, thus promoting their elongation and mediating SDF-1a induced MMP-9 metalloproteinase secretion and matrix invasion. Phosphatidic acid generated by DGKa promotes localization at cell protrusions of atypical PKCs which play an essential role downstream of DGKa by promoting Racmediated protrusion elongation and localized recruitment of b1 integrin and MMP-9. We finally demonstrate that activation of DGKa, atypical PKCs signaling and b1 integrin are all essential for MDA-MB-231 invasiveness. These data indicates the existence of a SDF-1a induced DGKa -atypical PKC -b1 integrin signaling pathway, which is essential for matrix invasion of carcinoma cells. 
Introduction
Most cancer-associated mortality is caused by metastatic dissemination of primary tumors and the outgrowth of secondary tumors at distant sites. Among the microenvironment signals sustaining the invasive phenotype of cancer cells, stromal cellderived factor-1a (SDF-1a, also named CXCL12), plays a major role in promoting cancer metastasis in several cancers, including breast cancer [1] . SDF-1a is a chemokine secreted by tumorassociated fibroblasts and bone marrow stromal cells, which through activation of its CXCR4 receptor, promotes migration and invasion of malignant cells and their homing to target organs [2, 3] . Indeed CXCR4 is a poor prognosis predictor in several cancer types [4] .
In breast cancer, the chemotactic and invasive activity of SDF1a/CXCR4 is mediated by both Ga 13 -mediated activation of RhoA and Gai-mediated activation of Rac1 via DOCK180/ ELMO, which regulate cytoskeletal remodeling [5, 6] . In myeloid cells, Rac1 mediates SDF-1a-induced increase of integrin affinity, while RhoA mediates formation of membrane protrusions and CXCR4 trafficking to the cell surface in Rab11+ endosomes [7, 8] . Moreover, in gastric cancer cells SDF-1a invasive and proliferative activity is also stimulated by Gai-and PI3Kb-mediated activation of mTOR complex 1, which contributes to Rac1 activation as well [9] . Finally, atypical protein kinases C (PKCf and i, hereafter aPKCs), which do not bind diacylglycerol (DG), play a key role in mediating chemotaxis of bone marrow and muscle stem cells, and of lymphocytes [10, 11] . However neither the mechanisms by which SDF-1a stimulates aPKCs nor their role in SDF-1a invasive signaling in breast cancer cells have been elucidated.
DGKs are a multigenic family of ten enzymes phosphorylating DG to generate phosphatidic acid (PA), thus reciprocally regulating in a highly compartmentalized manner the concentration of both lipid second messengers and their signaling activities [12] . Indeed, activation of DGKs results in the termination of DGmediated signals, while triggering PA-mediated ones. Increasing evidence points to DGKa as a critical node in oncogenic signaling and as a putative novel therapeutic target in cancer: inhibition or silencing of DGKa has been shown to reduce tumor growth and mortality in glioblastoma and hepatic carcinoma xenograft models [13, 14] . Moreover, we recently showed that DGKa activity sustains the pro-invasive activity of metastatic p53 mutations, by promoting the recycling of a5b1 integrin to the tip of invasive protrusions in tridimensional matrix [15] . DGKa is activated and recruited to the membrane by growth factors, estrogen and tyrosine kinase oncogenes through Src-mediated phosphorylation. Upon growth factor stimulation, activation of DGKa mediates cell migration, invasion and anchorage-independent growth [16] [17] [18] [19] [20] [21] . Indeed, activation of DGKa is a central element of a novel lipid signaling pathway involving PA-mediated recruitment at the plasma membrane and activation of aPKCs in a complex with RhoGDI and Rac1, thus providing a positional signal regulating Rac1 activation and association to the membrane [22, 23] .
Altogether these data suggest that DGKa and aPKCs may act as signaling nodes in the molecular crosstalk between soluble chemotactic factors and the extracellular matrix, thus prompting us to investigate the involvement of DGKa in cell migration and invasion induced by SDF-1a in breast cancer cells. In here we show that upon SDF-1a stimulation of breast cancer cells, DGKa activity mediates aPKCs localization at protrusion sites and the subsequent recruitment of b1 integrin and MMP-9 secretion. Conversely over-expression of DGKa is sufficient to induce aPKCs-dependent cell elongation. Finally, we observed that the DGKa -aPKCs -b1 integrin pathway is an essential mediator of chemokine-promoted cell migration and matrix invasion.
Materials and Methods

Cells Culture and Reagents
MDA-MB-231 cells were from ATCC, 293FT were from Life Technologies. Cells were cultured in DMEM (Life Technologies) with 10% FCS (LONZA) and antibiotics/antimycotics (SigmaAldrich) in humidified atmosphere 5% CO 2 at 37uC.
R59949 (Sigma-Aldrich) was dissolved in DMSO; equal amounts of DMSO were used in the control samples. All reagents are from Sigma-Aldrich apart: matrigel growth factor reduced (BD Bioscences), human recombinant SDF-1a and HGF (Peprotech), Myr-PKCf/i peptide inhibitor (BIOMOL) and NSC23766 (Tokris bioscience).
Antibodies: myc (clone 9E10 Santa Cruz), MMP-9 (2C3 Santa Cruz for western blotting and immunofluorescence or IC9111F RDsystems); PKCf/i (P0713 Sigma); b1 integrin (cat. 610467 BD Transduction Laboratories for western blotting and immunofluorescence or BV7 Abcam for cytofluorimetry); StrepMab-tag II (2-1507-001 IBA); actin (C-2 Santa Cruz); tubulin (DM1A SigmaAldrich); DGKa (Shaap et al., 1993), human RCP (rabbit in-house Ab raised against RCP residues 379-649); Cdc42 (2462 Cell signaling). Secondary antibodies HRP-mouse and HRP-rabbit were from Perkin Elmer. Secondary antibodies anti-rabbit Ig Alexa Flour-488 and anti-mouse Ig Alexa Flour-488 were from Life Technologies as well as Alexa Flour 546-phalloidin, TO-PRO-3 is from Life Technologies.
Invasion Assay
Invasion assay were performed in BD BioCoat Matrigel Chambers. 50,000 cells/well were plated in the upper chamber whereas SDF-1a (100 ng/ml) or 10% FCS were added to the lower chamber in serum free medium. After 22 hours of incubation in a humidified atmosphere 5% CO 2 at 37uC, non invading cells were removed from the upper surface of the membrane and invading cells were fixed and stained with DiffQuik (Medion Diagnostic) before counting.
Wound Healing Assay
Cells were grown to confluence in 12 wells plates and the monolayer wounded with a pipet tip. Cell debris were removed and monolayer maintained in serum free medium for 24 hours with or without HGF (50 ng/ml). The cells were stained with DiffQuik (Medion Diagnostic) and for each experimental point 8 fields photographed (Axiovert inverted microscope with a 4x objective and a digital camera). Cells migrating inside 2.3 mm of wound were counted.
DGKa Activation Assay
Cells homogenates were prepared by collecting the cells with a rubber scraper in buffer B (25 mM Hepes (pH 8), 10% glycerol, 150 mM NaCl, 5 mM EDTA, 2 mM EGTA, 1 mM ZnCl2, 50 mM ammonium molibdate, 10 mM NaF, 1 mM sodium orthovanadate and Protease Inhibitor Cocktail), homogenizing them with a 23 G syringe and by spinning at 500 g for 15 min. Protein concentration was determined by the bicinchoninic acid method (Pierce) and equalized for each point with buffer.
DGKa activity in cell homogenates (25 ml) was assayed by measuring initial velocities (5 min at 30uC) in presence of saturating substrates concentration (1 mg/ml diolein, 5 mM ATP, 3 mCi/ml c 32 P-ATP (Perkin Elmer), 10 mM MgCl2, 1 mM ZnCl2, 1 mM EGTA in 25 mM Hepes pH 8, final reaction volume 50 ml). Reaction was terminated with 0.1 M HCl and lipids were extracted with cloroform methanol (1:1). PA was separated by TLC in chloroform:methanol:water:25% ammonium hydroxide (60:47:11:4). 32 P-PA was identified by co-migration with PA standards stained by incubation in iodine chamber. Radioactive signals were detected and quantified by Molecular Imager (Bio-Rad).
Immunofluorescence
Cells (30,000/well) were plated on matrigel coated coverlips in 24 wells cell culture plate and serum deprived for 16-24 hours before stimulation. After stimulation cells were washed with PBS, fixed in PBS containing 3% paraformaldehyde and 4% sucrose and permeabilized in cold Hepes-Triton buffer (20 mM Hepes, 300 mM sucrose, 50 mM NaCl, 3 mM MgCl2, 0.5% Triton X-100, pH 7.4). PBS containing 2% BSA was used as blocking reagent for 15 minutes and as diluting agent for primary and secondary antibodies (incubated for at least 1 hour). Intermediate washing was performed with PBS containing 0.2% BSA.
Antibodies were added directly onto each glass coverslip in a humidified chamber. Finally, each glass coverslip was washed briefly in water and mounted onto a glass microscope slide using Mowiol (20% Mowiol 4-88, 2.5% 1, 4-diazabicyclo [2.2.2] octane in PBS, pH 7.4).
Confocal images were acquired with Leica confocal microscope TCS SP2 using a 63x objective, NA = 1.32, equipped with LCS Leica confocal software. Basal planes are shown. Each experimental point was performed in duplicate. Depending on preparation quality in each replicate roughly 30 images were taken, containing between 70 and 100 cells.
Morphometry
For cell length analysis cells were plated in 24 wells plates and phase contrast images of live cell were acquired with an Axiovert inverted microscope equipped with a 40x objective and a digital camera (Carl-Zeiss) and total cell length was measured with Image-Pro Plus software (MediaCybernetics). Alternatively in Fig. 6D and Fig. S5B we used a 10x Plan Fluor objective, NA 0.3, and an inverted microscope (TE200; Nikon) with a digital camera (CoolSNAP HQ; Photometrics) and Metamorph software (Molecular Devices). For each experimental condition 5 random fields were photographed containing more than 100 cells.
Cytofluorimetry
Cells were detached with ice could PBS 4 mM EDTA, fixed with PBS containing 3% paraformaldehyde and stained as indicated for 30 min. After washing with PBS containing 0.2% BSA cells were analyzed with a FACScalibur instrument an CellQuest software (BD) or Flowing software (Turku Bioimaging). siRNA PKCf sense 59CGUUCGACAUCAUCACCGAtt39an-tisense 59UCGGUGAUGAUGUCGAACGgg39.
siRNA for Transient Silencing
siRNA PKCi sense 59CGUUCGACAUCAUCACCGAtt39 antisense 59UCGGUGAUGAUGUCGAACGgg39.
siRNA b1 integrin sense 59GGAGGAAUGUUACACGGCU39 antisense 59 AGCCGUGUAACAUUCCUCCag 39. 
Generation of Tet-inducible Strep-tagged DGKa Construct and Cell Infection
Human DGKa was amplified from pMT2-DGKa [24] by PCR using the primers DGKa_ScII_fw (59-CCGCGGGCAG-CATGGCCAAGGAGAGGGGC-39) and DGKa_H3_rv (59-AAGCTTTTAGCTCAAGAAGCCAAA-39) and cloned into pEXPR-IBA-105 (IBA GmbH) via SacII and HindIII to generate pEXPR-Strep-DGKa. In a further step Strep-DGKa was amplified by PCR using primers IBA_fw_N1 (59-GCGGCCGCA-GACCCACCATGGCTAGC-39) and 105DGKa_MluI_rv (59-ACGCGTTTAGCTCAAGAAGCCAAA-39) and cloned via NotI and MluI to pLVX-Tight-Puro (Clontech). All constructs were verified by DNA sequencing.
The resulting pLVX-Tight-PURO-OST-DGKa presents OSTDGKa after a tetracycline controlled promoter and was used with the Lenti-X Tet-On Advanced Inducible Expression System (Clontec) according to manufacturer's instruction. Lentiviral particles were obtained in 293FT packaging cells co-transfected with helper vectors. After double infection and selection we obtained a polyclonal population of MDA-MB-231 cells expressing OST-DGKa in a tetracycline inducible manner. A control cell line was also generated with an empty vector.
Generation of MDA-MB-231 Stably Expressing Myc-DGKa
Myc-DGKa was amplified from PMT2-myc-DGKa [16] by PCR using the primers sense.
59CTCGAGACCAATGGAACAAAAGTTGATTTCAGAA-GAAGATTTATTAATGGCCAAGGAGG39, antisense 59GCCCCTCTCCTTGGCCATTAATAAATCTTCTTCT-GAAACAACTTTTGTTCCATGGCTCGAGTGCA39 and cloned in the pDONOR211 vector using the Gateway system (Life Technologies) according to manufacturer's instructions. The Gateway Technology (Life Technologies) was also used to subclone myc-DGKa into pLenti4/V5-DEST lentiviral vector. Lentiviral particles were obtained in 293FT packaging cells cotransfected with helper vectors. After infection and selection we obtained a polyclonal population of MDA-MB-231 cells constitutively expressing myc-DGKa.
Inducible Silencing of DGKa in MDA-MB-231
We used the commercial pTRIPZ Inducible Lentiviral Human DGKA shRNA Clone ID: V3THS_340705 (shRNA-DGKa1) or pTRIPZ Inducible Lentiviral Non-silencing shRNA Control RHS4743 (shRNA-CTRL). Those vectors express shRNA and turboRFP under a doxycycline regulated promoter (Thermo Scientific Open Biosystems). Lentiviral particles were obtained in 293FT packaging cells co-transfected with helper vectors. After infection and selection we obtained a polyclonal population of MDA-MB-231 cells which upon induction with doxycycline (1 mg/ml, 72 hours) are 100% RFP positive.
Stable Silencing DGKa in MDA-MB-231
The shRNA for DGKa (forward: 59 GATCCCCGGTCAGT-GATGTCCTAAAGTTCAAGAGACTTTAGGACATCACT-GACCTTTTTGGAAA reverse: 59 AGCTTTTC-CAAAAAGGTCAGTGATGTCCTAAAGTCTCTTGAACTT-TAGGACATCACTGACCGGG) was cloned with H1-Promoter within the lentiviral vector pCCL.sin.PPT.hPGK.GFPWpre [25] . The resulting vector co-express shRNA-DGKa and GFP (shRNADGKa2). Empty vector was used as a control. Lentiviral particles were obtained in 293FT packaging cells co-transfected with helper vectors (Life Technologies). At 1 week after infection nearly 100% of cells were GFP + .
Generation of ShRNA-b1 Integrin MDA-MB-231
ShRNA-b1integrin in pLKO were a kind gift of P. Defilippi [26] . Lentiviral particles were generated with Sigma Mission Lentivaral packaging mix according to manufacturer's instruction in 293FT cells and selected with puromycin. Empty pLKO was used as a control.
Western Blotting
To verified protein down-regulation cells were lysed 48 hours after transfection. Cell were washed with ice cold PBS, scraped on ice in lysis buffer (25 mM Hepes, pH 8, 150 mMNaCl, 0.5/1% Nonidet P-40, 5 mM EDTA, 2 mM EGTA, 1 mM ZnCl2, 50 mM NaF, 10% glycerol supplemented with fresh 1 mM Na 3 VO 4 , and protease inhibitors) and clarified after centrifugation of 15 minutes at 12000 rpm at 4uC. Samples were then resuspended in Laemmli buffer, heat denatured, and separated by SDS/PAGE. Proteins were then transferred on PVDF membrane by using semi-dry system. Membrane was then blocked with 5% BSA in PBS and incubated at 4uC overnight with primary antibodies diluted in TBS tween 0.1%, BSA 2%, 0.01% azide. After 4 washes with TBS-Tween 0.1%, membranes were incubated with secondary antibodies and washed again. Western blot were visualized using Western Lightning Chemiluminescence Reagent Plus (Perkin Elmer).
Quantitative RT-PCR
RNA was extracted by TRI-Reagent Solution (Life Technologies) retrotrascribed with High-Capacity cDNA Reverse Transcription Kits (Life Technologies) and cDNA quantified by real time PCR using GUSB as normalizer. TaqMan gene expression assays we from Life Technologies: b1 integrin (Hs 00559595), GUSB (Hs 00939627), DGKa (Hs 00176278) and MMP-9 (Hs 00234579).
MMP-9 Secretion
MDA-MB-231 cells (250,000 cells/well) were plated in 6-well cell culture plate and transfected with the indicated siRNA. After 24 hours in serum free media cells were treated with SDF-1a (100 ng/ml in 500 ml serum-free medium). After 24 hours the MMP-9 concentration in the supernatants was determined by ELISA assay (Life Technologies).
specific siRNA and lysed. The efficiency of DGKa down-regulation by siRNA was verified at 48 hours after transfection by western blot, tubulin was used as loading control. D) MDA-MB-231 cells were plated on matrigel-coated coverslips for 20 hours in FCS containing medium and cultured for further 20 hours in serum free medium. Cells were then stimulated for 6 hours with 50 ng/ml SDF-1a, in presence or in absence of 1 mM R59949, fixed and stained for actin (red) and aPKCs (green). Arrowheads indicate aPKCs at protrusions. Scale bar 24 mm. E) Histogram reports the percentage of cells displaying aPKCs at protrusions as mean 6 SE of 3 independent experiments with ***t-test p,0.0005. F) MDA-MB-231 cells (10 6 /well) were plated on matrigel invasion chamber and stimulates for 24 hours with SDF-1a (50 ng/ml) in presence or absence of PKCf pseudosubstrate (PS-PKCf, 10 mM). . DGKa and aPKCs mediate SDF-1a-induced recruitment of b1 integrin to pseudopods. A) MDA-MB-231 cells were plated on matrigel-coated coverslips for 20 hours in FCS containing medium, transfected with CTRL or DGKa-specific siRNA and cultured for further 20 hours in serum free medium. Cells were then stimulated for 6 hours with 50 ng/ml SDF-1a, fixed and stained for actin (red) and b1 integrin (green). Arrows indicate b1 integrin at protrusions. Scale bar 24 mm. B) Histogram reports the percentage of cells displaying b1 integrin at protrusions as mean 6 SE values of 3 independent experiments with **t-test p,0.005. C) MDA-MB-231 cells were plated on matrigel-coated coverslips for 20 hours in FCS containing medium and cultured for further 20 hours in serum free medium. Cells were then stimulated for 6 hours with 50 ng/ml SDF-1a, in presence or in absence of 1 mM R59949, fixed and stained for actin (red) and b1 integrin (green). Arrow indicates b1 integrin at protrusions. Scale bar 24 mm. D) Histogram reports the percentage of cells displaying b1 integrin at protrusions as mean 6 SE of 3 independent experiments with *t-test p,0.05, **t-test p,0.005. E) MDA-MB-231 cells were plated on matrigel-coated coverslips for 20 hours in FCS containing medium, transfected with CTRL or PKCf/i -specific siRNA and cultured for further 20 hours in serum free medium. Cells were then stimulated for 6 hours with 50 ng/ml SDF-1a, fixed and stained for actin (red) and b1 integrin (green). Arrowheads indicate b1 integrin at protrusions. Scale bar 24 mm. F) Histogram reports the percentage of cells displaying b1 integrin at protrusions as mean 6 SE of 3 independent experiments with **t-test p,0.005. G) MDA-MB-231 cells
Statistical Analysis
Data are shown as the mean 6 SEM. For statistical analysis, Student's t-test or ANOVA were used. Experiments shown are representative at least 3 independent experiments.
Results
DGKa Is Necessary for SDF-1a-induced Cell Invasion
We previously showed that DGKa is necessary for matrix invasion promoted by Epidermal Growth Factor (EGF) [15] or Hepatocyte Growth Factor (HGF) in MDA-MB-231 breast carcinoma cells [27] . In order to investigate the role of DGKa in chemokine invasive signaling in breast cancer, we knocked down DGKa in MDA-MB-231 using a lentiviral construct expressing a DGKa-specific shRNA under an inducible promoter (shRNA-DGKa1). This construct strongly downregulated DGKa expression when compared with parental cells or a non-targeting control sequence (shRNA-CTRL, Fig. 1 B and C) . The invasive ability of parental, DGKa-knocked down and control cells were evaluated in a Matrigel invasion assay. SDF-1a (100 ng/ml) doubles the number of parental as well as shRNA-CTRL MDA-MB-231 invading across the matrigel insert (Fig. 1 A) . Conversely, shRNA-DGKa1 cells were unresponsive to SDF-1a stimulation. We confirmed this finding with an independent shRNA (shRNADGKa2) giving a comparable inhibition of SDF-1a stimulated matrix invasion (Fig. S1 ), making off-target effects unlikely.
Those findings indicates that DGKa mediates the pro-invasive signaling promoted not only by tyrosine kinase receptors [22] but also by chemokine receptors involved in tumor cells metastatization, such as those of SDF-1a.
SDF-1a Stimulates DGKa Activity and Localization at Protrusions Sites
The previous findings that HGF, EGF and VEGF activate DGKa and promote its recruitment to the plasma membrane in epithelial and endothelial cells [15, 17, 22] suggest that SDF-1a may promote localized DGKa activation at ruffling sites. Despite its biological significance, the low level of DGKa expression in MDA-MB-231 cells hampers activation and localization studies of the endogenous protein with currently available antibodies.
Thus, for localization studies, MDA-MB-231 cells were stably infected with a lentiviral vector expressing myc-DGKa and plated on matrigel-coated coverslip to mimic the epithelial microenvironment. In unstimulated serum-deprived cells, myc-DGKa was mainly cytoplasmic, with some cells displaying very little accumulation at cell protrusions ( Fig. 2A) . Prolonged SDF-1a stimulation (50 ng/ml; 4 to 6 hours) resulted in the localization of DGKa at the tip of large protrusions ( Fig. 2A and B) . No detectable changes were observed at earlier time points (15 minutes, Fig. 2B ).
For enzymatic activation assays, we infected MDA-MB-231 with a lentiviral vector expressing OneStrep-Tagged DGKa (OST-DGKa) under the control of a doxycycline-inducible promoter. Upon 48 hours doxycycline treatment (1 mg/ml), OST-DGKa was strongly overexpressed as compared to endogenous protein (Fig. S2A ). Under these conditions the enzymatic activity of OST-DGKa was responsible for almost the entire DGK activity measured in cell homogenates. Both SDF-1a and HGF (a well known DGKa activator) induced a further moderate increase of OST-DGKa activity within 15 minutes of stimulation (Fig. 2C) .
Altogether these data indicate that SDF-1a regulates DGKa activity and localization and suggest that DGKa plays a role in the formation and/or extension of cell protrusions induced by SDF1a.
DGKa Mediates SDF-1a-induced Cell Invasion by Regulating aPKCs Recruitment to Cell Protrusions
DGKa, by producing PA, mediates aPKCs activation and recruitment to the cell surface induced by growth factors [23, 28] . Thus, we set to investigate whether DGKa mediates SDF-1a-induced cell invasion by regulating aPKCs. To investigate the role of DGKa in regulating aPKCs localization, MDA-MB-231 cells were transiently transfected with control (siRNA-CTRL) or DGKa-specific siRNA (siRNA-DGKa). Upon 48 hours from transfection with siRNA-DGKa, the expression of DGKa was nearly undetectable as compared to its expression in cells transfected with control siRNA (Fig. 3C) . Then, MDA-MB-231 cells were plated on matrigel-coated coverslips, serum starved and stimulated with 50 ng/ml SDF-1a for 6 hours. In control siRNA transfected cells, SDF-1a treatment significantly increased the percentage of cells displaying aPKCs at protrusions, while DGKa silencing strongly impaired aPKCs recruitment to the membrane (Fig. 3A and B) . In order to verify the requirement for DGKa enzymatic activity, we carried out aPKCs localization assays in presence or in absence of 1 mM R59949, a rather specific DGKa inhibitor [16, 29] . R59949 treatment completely abrogated aPKCs localization at protrusions induced by SDF-1a, while it did not affect aPKCs localization in unstimulated cells ( Fig. 3D and E) .
In order to investigate the role of aPKCs in SDF-1a-induced invasion through extracellular matrix, MDA-MB-231 cells were treated with 10 mM cell permeable PKCf pseudosubstrate (PSPKCf). In a matrigel invasion assay aPKCs inhibition significantly reduced SDF-1a-induced invasion, while basal invasion was unaffected in unstimulated cells (Fig. 3F) .
Altogether, these data demonstrate that in SDF-1a-stimulated breast carcinoma cells, localized activity of DGKa at pseudopodial tips provides a crucial localization lipid signal for aPKCs recruitment, thus mediating SDF-1a-induced invasive signaling.
DGKa and aPKCs Mediate SDF-1a-induced Recruitment of b1 Integrin to Protrusions Sites
Recycling and clustering of b1 integrin at the tip of invasive pseudopods is a key event sustaining the invasive properties of malignant cells [30] . Conversely, growth factors stimulate invasion both by inducing integrin clustering at actin-rich adhesive sites and lamellipodia and by stimulating integrin recycling [26, 31] . Thus, we set to investigate whether the DGKa and aPKCs at protrusions promote local accumulation of b1 integrin. In serum starved MDA-MB-231 cells plated on matrigel-coated coverslips b1 integrin is mostly localized in intracellular vesicles in the perinuclear/Golgi area. Upon SDF-1a stimulation, b1 integrin also localized in clusters at the tip of cell protrusions (Fig. 4A, C and E). However, either siRNA-mediated silencing of DGKa or R59949-mediated inhibition of its enzymatic activity impaired SDF-1a-induced localization of b1 integrin at cell extensions were transfected with CTRL and PKCf/i -specific siRNA and lysed. The efficiency of PKCf/i down-regulation by siRNA was verified by western bloting, tubulin was used as a loading control. H) MDA-MB-231 cells were infected with lentiviral vectors expressing a shRNA against b1-integrin (shRNA-b1) or a control sequence (shRNA-CTRL). 50,000 cells were plated on matrigel invasion chamber and incubated for 24 hours in presence or in absence of SDF-1a (100 ng/ml). Histogram reports mean 6 SE of fold over control values from 3 independent experiments with *t-test p,0.05, **t-test p,0.01. I) The efficiency of b1-integrin down-regulation by shRNA was verified by quantitative RT-PCR. doi:10.1371/journal.pone.0097144.g004
DGKa/aPKCs/b1 Pathway in Matrix Invasion PLOS ONE | www.plosone.org Figure 5 . DGKa and aPKCs mediates MMP-9 secretion and localization at protrusions. A) MDA-MB-231 cells were transfected with CTRL or DGKa -specific siRNA and shifted to serum free media. After 24 hours cells were treated with 100 ng/ml SDF-1a in serum free medium for further 20 hours. MMP9 content in the supernatants was measured by ELISA assay, histogram reports secreted MMP-9 as mean 6 SE of 3 independent (Fig. 4A, B, C and D) . Interestingly SDF-1a stimulation and DGKa inhibition did not affect the expression of b1 integrin at the cell surface, as measured by FACS analysis (Fig. S4A) . Since DGKa promotes Rac1 activation and membrane ruffles by regulating aPKCs [15] and as DGKa mediates SDF-1a-induced aPKCs recruitment to the membrane protrusions, we assessed whether aPKCs controls b1 integrin localization. Indeed, siRNAmediated silencing of aPKCs (Fig. 4G ) impaired SDF1-a-induced localization of b1 integrin at cell protrusions ( Fig. 4E and F) .
Altogether these data suggest that SDF-1a, by activating the DGKa/aPKCs pathway, stimulates the clustering of b1 integrin at cell protrusions, rather than stimulating its bulk translocation at the plasma membrane.
Since the expression of constitutively-membrane bound myrDGKa stimulates cell invasion by triggering RCP-mediated recycling of integrin a5b1 [15] , we set to investigate the role of b1 integrin in SDF-1a-promoted cell invasion. To this purpose we used shRNA mediated knockdown of b1 integrin which resulted in an 80% reduction of its expression in MDA-MB-231 cells (Fig. 4I) . We found that, b1 integrin knock down severely impaired the ability of MDA-MB-231 cells to invade through matrigel in response to SDF-1a stimulation (Fig. 4H) .
Altogether these data indicate that DGKa, by regulating aPKCs, controls chemokine-induced b1 integrin localization at protrusion sites in breast carcinoma cells, thus confirming the pivotal role of b1 integrin in SDF-1a-promoted matrix invasion.
DGKa and aPKCs Mediate SDF-1a-induced MMP-9 Secretion and Localization at Protrusions
Secretion of matrix metalloproteinases (MMPs) is involved in the extracellular matrix degradation required for invasion of cancer cells [32, 33] . SDF-1a stimulates the secretion of MMP-9 in several cancer cells, including MDA-MB-231 cells [34, 35] . In migrating cells, MMP-9 is addressed to the cellular extensions involved in cell migration and accumulates at their tips [36] . Thus, we investigated whether SDF1-a regulates intracellular localization and secretion of MMP-9 through the DGKa/aPKCs axis.
MDA-MB-231 cells presented a low, constitutive secretion of MMP-9 (40-80 pg/ml in the supernatant), which was not affected by SDF-1a but was severely reduced by siRNA-mediated silencing of DGKa (Fig. 5A) . However, the mRNA levels of MMP-9 were not affected by either SDF-1a stimulation or DGKa inhibition, suggesting that this pathway does not regulate MMP-9 at the transcriptional level in these cells (Fig. S4C) . Conversely, SDF-1a stimulated MMP-9 accumulation at protrusions of serum-starved MDA-MB-231 plated on matrigel-coated coverslips (Fig. 5B to E) . We cannot rule out that MMP-9 staining may be associated to the plasma membrane, indeed FACS analysis of these cells detected low amounts of membrane-bound MMP-9 with a small increase in MMP-9 surface positive cells following SDF-1a stimulation (Fig.  S4B) . Silencing of DGKa impaired MMP-9 translocation induced by SDF-1a, while it did not affect its localization in unstimulated cells (Fig. 5B and C) . Similarly, DGKa pharmacological inhibition with R59949, completely impaired MMP-9 recruitment induced by SDF-1a ( Fig. 5D and E) .
Altogether these data suggest that DGKa is essential for MMP-9 accumulation at protrusions and subsequent release in the extracellular space. Given the role of DGKa in regulating aPKCs, we investigated whether aPKCs mediates SDF-1a-induced regulation of MMP-9 localization. Indeed, siRNA-mediated silencing of aPKCs blunted SDF-1a induced MMP-9 localization at pseudopodial tips ( Fig. 5F and G) .
Altogether these data demonstrate that activation of the DGKa/aPKCs pathway drives both MMP-9 and b1 integrin localization at the pseudopodial tips, thus regulating the extension of invasive protrusions and sustaining the invasive behavior of MDA-MB-231 cells.
DGKa Overexpression Promotes aPKC/Rac Dependent Cell Elongation
We observed that prolonged SDF1a treatment (6 hours, 50 ng/ ml) of matrigel plated MDA-MB-231 promotes the transition to an elongated shape with the extension of long protrusions. Interestingly both siRNA downregulation of DGKa and R59949-mediated inhibition impairs this change in shape (Fig. S3A to C) indicating the crucial requirement of DGKa activity.
Since the over-expression of membrane-bound myr-DGKa stimulates cell migration in untransformed cells [18] and pseudopod extension and invasion in A2780 ovarian cancer cells [15] , we investigated whether wild type DGKa over-expression was sufficient to further stimulate invasion in MDA-MB-231 cells. The previously described inducible OST-DGKa construct in MDA-MB-231 cells allowed us to verify this issue as doxycycline treatment induced a 30-fold increase in DGKa expression (Fig. 6A and Fig. S2A) , with an increase of about 300-fold of the enzymatic activity (Fig. 2C) . However, over-expression of OST-DGKa was not sufficient to enhance migration of MDA-MB-231 in woundhealing assay or to increase invasion through matrigel (Fig. S2B  and C) . Nevertheless, over-expression of OST-DGKa led to elongation of serum-starved MDA-MB-231 cells, while doxycycline did not affect the cell length of empty vector-infected MDA-MB-231 cells (Fig. 6B and D) . Both in elongated and in shorter cells, OST-DGKa is localized at the tip of cell protrusions (Fig. 6C) suggesting that despite the absence of cytokines and growth factors the strong up-regulation of DGKa activity is sufficient to recruit the signaling machinery for membrane extension and to establish a feed forward loop recruiting further DGKa.
Consistently, with the reported role of the aPKCs in mediating DGKa-dependent Rac activation and membrane protrusions [23] , we observed that siRNA-mediated silencing of aPKCs (Fig. 6G) blunted cell elongation induced by OST-DGKa overexpression (Fig. 6E) . Also the Rac inhibitor NSC23766 completely experiments normalized for control, with *t-test p,0.05. B) MDA-MB-231 cells were plated on matrigel-coated coverslips for 20 hours in FCS containing medium, transfected with CTRL or DGKa -specific siRNA and cultured for further 20 hours in serum free medium. Cells were stimulated for 6 hours with 50 ng/ml SDF-1a, fixed and stained for actin (red) and MMP-9 (green). Arrowhead indicates MMP-9 at protrusions. Scale bar 24 mm. C) Histogram reports the percentage of cells displaying MMP-9 at protrusions as mean 6 SE of 3 independent experiments with ***t-test p,0.0005. D) MDA-MB-231 cells were plated on matrigel-coated coverslips for 20 hours in FCS containing medium and cultured for further 20 hours serum free medium. Cells were stimulated for 6 hours with 50 ng/ml SDF-1a, in presence or in absence of 1 mM R59949, fixed and stained for actin (red) and MMP-9 (green). Arrowhead indicates MMP-9 at protrusions. Scale bar 24 mm. E) Histogram reports the percentage of cells displaying MMP-9 at protrusions as mean 6 SE of 3 independent experiments with **t-test p,0.005, ***t-test p,0.01. F) MDA-MB-231 cells were plated on matrigelcoated coverslips for 20 hours in FCS containing medium, transfected with CTRL or PKCf/i -specific siRNA and cultured for further 20 hours in serum free medium. Cells were then stimulated for 6 hours with 50 ng/ml SDF-1a, fixed and stained for actin (red) and MMP-9 (green). Arrowhead indicates MMP-9 at protrusions. Scale bar 24 mm. G) Histogram reports the percentage of cells displaying MMP-9 at protrusions as mean 6 SE of 3 independent experiments with *t-test p,0.05, **t-test p,0.005. doi:10.1371/journal.pone.0097144.g005
DGKa/aPKCs/b1 Pathway in Matrix Invasion PLOS ONE | www.plosone.org Figure 6 . DGKa overexpression promotes a PKC-dependent cell elongation. MDA-MB-231 cells were infected with lentiviral vector expressing inducible OST-tagged DGKa or an empty vector. To induce DGKa expression, cells were treated overnight with doxycycline (1 mg/ml) in serum free medium. A) After cell lysis OST-DGKa induction was verified by western blotting with an antibody recognizing the OST-tag, while the blunted OST-DGKa induced elongation indicating the involvement of Rac family GTPases (Fig. 6F) . Those findings confirm the relevance of aPKCs and Rac as DGKa downstream effectors promoting cytoskeletal remodeling and extension of membrane protrusions.
The expression of myr-DGKa drives pseudopodial extension by stimulating RCP-mediated recycling of b1 integrin in A2780 carcinoma cells [15] . However, siRNA-mediated silencing of either b1 integrin or RCP (Fig. S5C and D) did not affect protrusion elongation induced by wild type DGKa in serum starved MDA-MB-231 cells (Fig. S5A and B) , suggesting that in this experimental model b1 integrin and its RCP-mediated recycling are not required for protrusion elongation.
These data indicate that up-regulation of DGKa activity by SDF-1a is sufficient to promote the extension of membrane protrusions through the aPKCs -RhoGDI -Rac pathway [22, 23] , but that additional signaling pathways and/or its localization at specific myrstyoilation-directed membrane compartment are required to trigger cells invasion.
Discussion
We and others established the relevance of DGKa activation and membrane recruitment in growth factors signaling [37] . In normal epithelia, endothelia and lymphocytes DGKa activity is required to convey proliferative [17, 38, 39] and migratory [16] [17] [18] 22, 23] signaling. Several studies pointed out DGKa involvement in cancer showing that its activity is necessary in vivo for glioblastoma and hepatocellular carcinoma progression [13] , and in vitro for proliferation and survival of endometrial carcinoma [21] , anaplastic large cell lymphoma [19] , and melanoma [40] . Moreover, DGKa activity mediates matrix invasion sustained by p53 pro-metastatic mutations in cancer cells [15] . However, the molecular pathways by which DGKa controls carcinoma formation and metastatization are poorly known.
Inhere we investigated the role of DGKa in invasive signaling of SDF-1a, one of the key signals driving metastasis [41] , whose receptor, CXCR4, is strongly associated to tumor growth and spontaneous metastasis formation [1] . We used MDA-MB-231 cells, a highly invasive human breast cancer cell line, whose invasiveness and tumorigenicity are dependent on the expression of SDF-1a receptor, CXCR4 [42] [43] [44] . In these cells we had previously shown that DGKa is required for EGF- [15] and HGFinduced [27] migration in a tridimensional environment.
Interestingly, we show here that DGKa is also regulated by SDF-1a, which stimulates its enzymatic activity and promotes its recruitment at ruffling sites (Fig. 2) . Moreover, we show that activation of DGKa provides a key lipid signal required for SDF1a pro-invasive activity in MDA-MB-231 cells (Fig. 1) .
We previously showed that the PA generated by HGF-induced activation of DGKa recruits to the plasma membrane and activates aPKCs in a complex with RhoGDI and Rac1, thus mediating the release of Rac1 from RhoGDI, and its localization and activation at ruffle sites [23] . The aPKCs subfamily comprises the f and i isoforms, which are activated by PA [28] but insensitive to DG.
Several pieces of evidence show that aPKCs and in particular PKCi, play a key role in cancer cell invasion and tumor progression [45] . Interestingly, PKCi is essential for K-Ras-driven invasion in colon cancer by regulating Rac1 [46] , while aPKCs mediates EGF-induced cell migration of MDA-MB-231 breast cancer cells [47] . Altogether these data further suggest that the DGKa/aPKCs signaling axis contributes to pro-invasive signaling.
Accordingly, the finding that SDF-1a induces aPKCs localization at protrusion sites through activation of DGKa, indicates that the DGKa/aPKCs signaling axis mediates chemokine-driven mammary carcinoma invasiveness (Fig. 3) . DGKa-dependent recruitment of aPKCs at protrusion is an essential signaling event, since the silencing of either DGKa or aPKCs impairs downstream events such as accumulation of b1 integrin and MMP-9 at the plasma membrane (Fig. 4 and 5) . The functional relevance of aPKCs as a DGKa effector is further proved by the observation that its silencing impairs DGKa-induced cell elongation (Fig. 6E) and that its inhibition blocks SDF-1a-induced matrix invasion (Fig. 3F) .
The findings that aPKCs, RCP and b1 integrin are all required for the invasiveness of MDA-MB-231 (Fig. 3F, 4H and ref. [15] ), and that upon SDF-1a stimulation b1 integrin is concentrated at protrusion tips in a DGKa and aPKCs-dependent manner, are consistent with our previous data showing that DGKa-generated PA, through binding to RCP, docks a5b1 recycling vesicles to the tips of invasive pseudopods. Altogether these findings suggest that activation of aPKCs may also contribute to integrin recycling induced by chemokines and growth factors, although there is no experimental evidence for it.
Several pieces of evidence in different cell types indicate that activation of aPKCs regulates MMPs production and secretion [48] . For instance, PKCf activation mediates MMP-9 secretion induced by SDF-1a in hematopoietic progenitors [11] . MMPs are key players in the tumor microenvironment and play a major role in invasion of extracellular matrix [49] . While some MMPs are transmembrane proteins, most of them are soluble and bind to the extracellular cell surface by interaction with several membrane proteins, including b1 integrin and CD44v [50] [51] [52] [53] [54] .
Our finding that both DGKa and aPKCs are required for SDF1a-induced release of MMP9 in the cell medium and for its accumulation at protrusions, provides further strength to our thesis that DGKa/aPKCs axis is a major component of chemokine proinvasive signaling. Interestingly, in SDF-1a-stimulated cells, MMP-9 localization at cell surface superimposes with that of b1 integrin, suggesting that their function at protrusion tips is coordinately regulated by activation of DGKa/aPKCs signaling. E) MDA-MB-231 cells expressing OST-DGKa were transiently transfected with control or PKCf/i-specific siRNA. After 48 hours DGKa expression was induced by overnight treatment with doxycycline (1 mg/ml) in serum free medium. Images were acquired with a phase contrast microscope, representative images are shown. Scale bar 50 mm. Total cell length was measured for at least 100 cells and reported as box and whiskers plot. F) MDA-MB-231 cells expressing OST-DGKa were induced by overnight treatment with doxycycline (1 mg/ml) in serum free medium with or without NSC23766 (100 mM). Images were acquired with a phase contrast microscope, representative images are shown. Scale bar 50 mm. Total cell length was measured for at least 100 cells and reported as box and whiskers plot. MDA-MB-231 cells were transfected with CTRL and PKCf/i -specific siRNA and lysed. The efficiency of PKCf/i down-regulation by siRNA was verified by western blotting, tubulin was used as a loading control. doi:10.1371/journal.pone.0097144.g006
DGKa/aPKCs/b1 Pathway in Matrix Invasion Finally, the observation that DGKa over expression drives by itself elongation of cell protrusions by regulating aPKCs is consistent with active PKCf promoting wide cytoskeletal remodeling and protrusions in untrasformed cells [23] . The molecular mechanisms by which aPKCs induces cell elongation downstream to DGKa is still partially known. In line with our previous demonstration that activation of the DGKa/aPKCs signaling module stimulates the RhoGDI driven localization of both Rac1 and Cdc42 at membrane ruffles, we observed that the Rac inhibitor NSC23766 blunts DGKa induced cell elongation (Fig. 6G) and that SDF-1a-induced localization of Cdc42 at protrusions of MDA-MB-231 cells is significantly reduced by DGKa inhibition (Fig. S3D and E) . Conversely, protrusion extension occurs even in the absence of b1 integrin and RCP, suggesting that DGKa-dependent activation of aPKCs regulates cytoskeletal remodeling independently from b1 integrin recycling and function, which are required, however, to enable cell migration through a 3D matrix (Fig. 4H) . While it is clear that DGKa/aPKCs activity on cell elongation is independent on b1 integrin recycling, these data cannot rule out that accumulation of b1 integrin and MMP-9 at protrusion tips depends on DGKa/ aPKCs-induced regulation of Rac1 or Cdc42 and cytoskeletal contractility [31] .
Altogether we showed that activation of the DGKa/aPKCs/b1 integrin pathway plays a key role in chemokine-driven matrix invasion in breast cancer cells. Those observations suggest that DGKa inhibition or silencing could be effective not only in reducing primary tumor growth in vivo [13, 14] but could potentially also reduce the metastatic potential of carcinoma cells. Figure S1 DGKa is necessary for SDF-1a-induced cell invasion. MDA-MB-231 cells were infected with lentiviral vectors expressing a shRNA against DGKa (shRNA-DGKa2) or an empty vector. A) Cells were lysed and the efficiency of DGKa down-regulation by shRNA was verified by western blot, tubulin was used as a loading control. B) 50,000 cells were plated on matrigel invasion chamber and incubated for 24 hours in presence or in absence of SDF-1a (100 ng/ml). Histogram reports mean 6 SE of fold over control values from 3 independent experiments with *t-test p,0.05, ***t-test p,0.0005. (TIF) Figure S2 DGKa overexpression does not affect migration and invasion of MDA-MB-231 cells. MDA-MB-231 cells were infected with lentiviral vector expressing inducible OSTtagged DGKa or an empty vector. To induce DGKa expression, cells were treated overnight with doxycycline (1 mg/ml) in serum free medium. A) After cell lysis, the extent of DGKa overexpression was verified with anti DGKa antibodies, long and short exposures are shown. Actin was used as loading control. B) Cells were grown to confluence in 12 well plates and subjected to a wound healing assay for 24 hours in serum free medium. HGF (50 ng/ml) was used as a positive control. The cells were stained and those migrating inside 2.3 mm of wound counted. Histogram reports mean 6 SE of fold over control values from 3 independent experiments with *t-test p,0.05. C) 50,000 cells were plated on matrigel invasion chamber and incubated for 24 hours in serum free medium. Medium with 10% FCS was used as positive control. Histogram reports mean 6 SE of fold over control values from 3 independent experiments with *t-test p,0.05. (TIF) Figure S3 DGKa is required for SDF-1a-induced pseudopod elongation. A) MDA-MB-231 cells were plated on matrigel-coated coverslips for 20 hours in FCS containing medium, transfected with CTRL or DGKa -specific siRNA and cultured for further 20 hours in serum free medium. Cells were then stimulated for 6 hours with 50 ng/ml SDF-1a, fixed and photographed at phase contrast. B) Histogram reports protrusions length in mm as mean 6 SE values of 4 independent experiments with *t-test p,0.005. C) MDA-MB-231 cells were plated on matrigel-coated coverslips for 20 hours in FCS containing medium and cultured for further 20 hours in serum free medium. Cells were then stimulated for 6 hours with 50 ng/ml SDF-1a, in presence or in absence of 1 mM R59949, fixed and photographed at phase contrast. Histogram reports protrusions length in mm as mean 6 SE of 3 independent experiments with *t-test p,0.005. D) MDA-MB-231 cells were plated on matrigel-coated coverslips for 20 hours in FCS containing medium and cultured for further 20 hours serum free medium. Cells were stimulated for 6 hours with 50 ng/ml SDF-1a, in presence or in absence of 1 mM R59949, fixed and stained for actin (red) and Cdc42 (green). Arrowhead indicates Cdc42 at protrusions. Scale bar 24 mm. E) Histogram reports the percentage of cells displaying Cdc42 at protrusions as mean 6 SE of 3 independent experiments with *ttest p,0.05. (TIF) Figure S4 SDF-1a is not affecting surface exposition of b1-integrin and MMP-9. A) Surface expression of b1 integrin was analyzed before (turquoise) and after (red) SDF-1a stimulation. Flow cytometry histogram overlay comparing the level of b1 integrin expression before and after SDF-1a expression. Isotypematched controls mAb staining are given as dashed lines. MFI, median fluorescence intensity. B) Surface expression of MMP-9 was analyzed before (turquoise) and after (red) SDF-1a stimulation. Flow cytometry histogram overlay comparing the level of MMP-9 expression before and after SDF-1a expression. Isotypematched controls mAb staining are given as dashed lines. MFI, median fluorescence intensity. C) MDA-MB-231 cells were plated on 6 wells dish for 20 hours in FCS containing medium and cultured for further 20 hours serum free medium. Cells were stimulated for 24 hours with 100 ng/ml SDF-1a, in presence or in absence of 1 mM R59949. MMP-9 mRNA was quantified by quantitative RT-PCR. Histogram reports the mean 6 SE of 3 independent experiments. (TIF) Figure S5 DGKa promoted cell elongation is independent from b1 integrin and RCP. MDA-MB-231 cells were infected with lentiviral vector expressing inducible OST-tagged DGKa or an empty vector. A) Cells were transiently transfected with control or b1 integrin-specific siRNA. After 48 hours DGKa expression was induced by overnight treatment with doxycycline (1 mg/ml) in serum free medium. Images were acquired with a phase contrast microscope, representative images are shown. Scale bar 50 mm. Total cell length was measured for at least 100 cells and reported as box and whiskers plot. B) Cells were transiently transfected with control or RCP-specific siRNA. After 48 hours DGKa expression was induced by overnight treatment with doxycycline (1 mg/ml) in serum free medium. Images were acquired with a phase contrast microscope, representative images are shown. Scale bar 50 mm. Total cell length was measured for at least 100 cells and reported as box and whiskers plot. C) MDA-MB-231 cells were transfected with CTRL and b1 integrin-specific siRNA and lysed. The efficiency of b1 integrin down-regulation by siRNA was verified by western blotting, tubulin was used as a 
Supporting Information
